Figure 3.
Proportion of subjects with sperm concentrations of >0, ≥1.0, and ≥15.0 × 106/mL by ITT analysis at 0 month, 6th month, and 18th month.
0 month, the patients had no treatment; 6th month, the patients had received 6 months of hCG monotherapy; 18th month, the patients had received 6 month of hCG monotherapy and an additional 12 month of hCG and uFSH combination therapy. ns, not significant
